JPWO2022163846A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022163846A5 JPWO2022163846A5 JP2022578533A JP2022578533A JPWO2022163846A5 JP WO2022163846 A5 JPWO2022163846 A5 JP WO2022163846A5 JP 2022578533 A JP2022578533 A JP 2022578533A JP 2022578533 A JP2022578533 A JP 2022578533A JP WO2022163846 A5 JPWO2022163846 A5 JP WO2022163846A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- antibody
- agent
- tert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021014624 | 2021-02-01 | ||
| JP2021014624 | 2021-02-01 | ||
| JP2021066316 | 2021-04-09 | ||
| JP2021066316 | 2021-04-09 | ||
| PCT/JP2022/003512 WO2022163846A1 (ja) | 2021-02-01 | 2022-01-31 | 抗体－免疫賦活化剤コンジュゲートの新規製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022163846A1 JPWO2022163846A1 (https=) | 2022-08-04 |
| JPWO2022163846A5 true JPWO2022163846A5 (https=) | 2025-02-10 |
| JP7846634B2 JP7846634B2 (ja) | 2026-04-15 |
Family
ID=82654680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022578533A Active JP7846634B2 (ja) | 2021-02-01 | 2022-01-31 | 抗体－免疫賦活化剤コンジュゲートの新規製造方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240150390A1 (https=) |
| EP (1) | EP4286393A4 (https=) |
| JP (1) | JP7846634B2 (https=) |
| KR (1) | KR20230142544A (https=) |
| BR (1) | BR112023012932A2 (https=) |
| CA (1) | CA3207210A1 (https=) |
| IL (1) | IL304855A (https=) |
| TW (1) | TW202241454A (https=) |
| WO (1) | WO2022163846A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3168368A1 (en) * | 2020-03-06 | 2021-09-10 | Masayuki Ishizaki | Antibody-drug conjugate including novel cyclic dinucleotide derivative |
| US20250207169A1 (en) | 2022-03-02 | 2025-06-26 | Daiichi Sankyo Company, Limited | METHOD FOR PRODUCING Fc-CONTAINING MOLECULE |
| JP2025166269A (ja) * | 2022-07-29 | 2025-11-06 | 第一三共株式会社 | 抗腫瘍効果を有する抗体薬物複合体の新規製造方法 |
| AU2023336004A1 (en) | 2022-08-29 | 2025-03-06 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate including mutant fc region |
| AU2024324648A1 (en) * | 2023-08-14 | 2026-02-26 | Cancer Targeted Technology Llc | Psma binding ligand-linker conjugates and methods for use thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US5885573A (en) | 1993-06-01 | 1999-03-23 | Arch Development Corporation | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| EP1392359B2 (en) | 2001-05-11 | 2013-03-13 | Ludwig Institute for Cancer Research Ltd. | Specific binding proteins and uses thereof |
| CN100506277C (zh) | 2001-11-01 | 2009-07-01 | Uab研究基金会 | 肿瘤坏死因子相关细胞凋亡诱导配体受体的选择性抗体和其它治疗剂的联合体系 |
| ES2392525T3 (es) | 2002-07-15 | 2012-12-11 | F. Hoffmann-La Roche Ag | Tratamiento del cáncer con el anticuerpo dirigido contra ErbB2 rhuMAb 2C4 |
| AU2004213053C1 (en) | 2003-02-20 | 2009-07-16 | Seagen Inc. | Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| WO2005092909A1 (ja) | 2004-03-25 | 2005-10-06 | Toudai Tlo, Ltd. | 立体規則性の高いリボヌクレオチド類縁体及びデオキシリボヌクレオチド類縁体の製造法 |
| CA2623236A1 (en) | 2005-09-26 | 2007-04-05 | Medarex, Inc. | Human monoclonal antibodies to cd70 |
| HRP20170407T1 (hr) | 2007-08-30 | 2017-05-05 | Daiichi Sankyo Company, Limited | Anti-epha2 anitijelo |
| WO2011003018A2 (en) | 2009-07-01 | 2011-01-06 | Cornell University | Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof |
| CA2767253A1 (en) * | 2009-07-06 | 2011-01-13 | Ontorii, Inc. | Novel nucleic acid prodrugs and methods of use thereof |
| US8809496B2 (en) | 2009-09-03 | 2014-08-19 | The Noguchi Institute | Production method of 11-sugar sialylglycopeptide |
| DK2907824T3 (en) | 2012-10-11 | 2018-07-23 | Daiichi Sankyo Co Ltd | ANTIBODY-drug conjugate |
| WO2014124430A1 (en) | 2013-02-11 | 2014-08-14 | Emory University | Nucleotide and nucleoside therapeutic compositions and uses related thereto |
| RS59500B1 (sr) | 2013-05-18 | 2019-12-31 | Aduro Biotech Inc | Sastavi i metode za aktiviranje signaliziranja koje je zavisno od „stimulatora gena za interferon“ |
| EP2996472B1 (en) | 2013-05-18 | 2019-03-27 | Aduro Biotech, Inc. | Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling |
| SI3043803T1 (sl) | 2013-09-11 | 2022-09-30 | Emory University | Nukleotidne in nukleozidne sestave in njihova uporaba |
| LT3424955T (lt) | 2013-12-25 | 2025-06-25 | Daiichi Sankyo Company, Limited | Anti-trop2 antikūno ir vaisto konjugato gamybos būdas |
| PE20170198A1 (es) | 2014-06-04 | 2017-04-08 | Glaxosmithkline Ip Dev Ltd | Dinucleotidos ciclicos como moduladores de sting |
| DE102014214408A1 (de) | 2014-07-23 | 2016-01-28 | Wacker Chemie Ag | Härtbare Organopolysiloxanzusammensetzungen |
| US11559581B2 (en) | 2015-01-09 | 2023-01-24 | Oxford University Innovation Limited | Antibody conjugates and methods of making the antibody conjugates |
| HK1248603A1 (zh) | 2015-03-10 | 2018-10-19 | Aduro Biotech, Inc. | 用於活化"干扰素基因的刺激剂"依懒性信号传导的组合物和方法 |
| TWI704154B (zh) | 2015-12-03 | 2020-09-11 | 英商葛蘭素史克智慧財產發展有限公司 | 新穎化合物 |
| EP4159749A3 (en) | 2016-07-01 | 2023-06-14 | Daiichi Sankyo Company, Limited | A method for producing fc-containing molecule with remodeled sugar chain |
| US10537590B2 (en) | 2016-09-30 | 2020-01-21 | Boehringer Ingelheim International Gmbh | Cyclic dinucleotide compounds |
| JP7164540B2 (ja) * | 2017-03-29 | 2022-11-01 | ロシュ イノベーション センター コペンハーゲン エーエス | 立体的に規定されたホスホロチオエートオリゴヌクレオチドの調製のための直交保護基 |
| TW202532102A (zh) | 2017-05-15 | 2025-08-16 | 日商第一三共股份有限公司 | 抗體－藥物結合物及其用途 |
| WO2019006455A1 (en) * | 2017-06-30 | 2019-01-03 | Solstice Biologics, Ltd. | AUXILIARIES OF CHIRAL PHOSPHORAMIDITIS AND METHODS OF USE THEREOF |
| IL301637B2 (en) | 2017-09-29 | 2024-10-01 | Daiichi Sankyo Co Ltd | Antibody-pyrrolobenzodiazepine derivative conjugate |
| CN114269764A (zh) * | 2018-05-02 | 2022-04-01 | 株式会社纳蒂亚斯 | 立体控制寡核苷酸合成用光学活性片段及其制造方法、以及使用其的立体控制寡核苷酸的合成方法 |
| KR102567590B1 (ko) | 2018-09-06 | 2023-08-17 | 다이이찌 산쿄 가부시키가이샤 | 신규 고리형 디뉴클레오티드 유도체 및 그 항체 약물 콘쥬게이트 |
| CA3168368A1 (en) | 2020-03-06 | 2021-09-10 | Masayuki Ishizaki | Antibody-drug conjugate including novel cyclic dinucleotide derivative |
-
2022
- 2022-01-28 TW TW111103962A patent/TW202241454A/zh unknown
- 2022-01-31 US US18/263,124 patent/US20240150390A1/en active Pending
- 2022-01-31 CA CA3207210A patent/CA3207210A1/en active Pending
- 2022-01-31 WO PCT/JP2022/003512 patent/WO2022163846A1/ja not_active Ceased
- 2022-01-31 JP JP2022578533A patent/JP7846634B2/ja active Active
- 2022-01-31 BR BR112023012932A patent/BR112023012932A2/pt unknown
- 2022-01-31 EP EP22746065.6A patent/EP4286393A4/en active Pending
- 2022-01-31 KR KR1020237029436A patent/KR20230142544A/ko active Pending
-
2023
- 2023-07-30 IL IL304855A patent/IL304855A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12606634B2 (en) | Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 | |
| JP7846634B2 (ja) | 抗体－免疫賦活化剤コンジュゲートの新規製造方法 | |
| JPWO2022163846A5 (https=) | ||
| CN115209921B (zh) | 包含环状二核苷酸衍生物的抗体药物偶联物 | |
| EP3949987A1 (en) | Anti-her2 antibody-pyrrolobenzodiazepine derivative conjugate | |
| BR112021009251A2 (pt) | conjugado anticorpo-fármaco, anticorpo ou um fragmento funcional do mesmo, polinucleotídeo, vetor de expressão, célula hospedeira, composição farmacêutica, e, métodos para produção de um anticorpo com glicano remodelado, de um conjugado anticorpo-fármaco, do anticorpo ou um fragmento funcional do mesmo e para tratamento de um tumor. | |
| WO2024024935A1 (ja) | 抗腫瘍効果を有する抗体薬物複合体の新規製造方法 | |
| HK40103687A (en) | Novel method for producing antibody-immunostimulator conjugate | |
| CN116867795A (zh) | 抗体－免疫刺激剂偶联物的新型制造方法 | |
| RU2836814C1 (ru) | Конъюгат антитело-лекарственное средство, содержащий новое производное циклического динуклеотида | |
| HK40086596A (en) | Antibody-drug conjugate including novel cyclic dinucleotide derivative | |
| HK40068279A (en) | Anti-her2 antibody-pyrrolobenzodiazepine derivative conjugate | |
| HK40031007A (en) | Antibody-pyrrolobenzodiazepine derivative conjugate | |
| HK40068280A (en) | Antibody-pyrrolobenzodiazepine derivative conjugate |